Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11,802 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pre-treatment maximum standardized uptake value predicts outcome after frontline therapy in patients with advanced stage follicular lymphoma.
Strati P, Ahmed MA, Fowler NH, Nastoupil LJ, Samaniego F, Fayad LE, Hagemeister FB, Romaguera JE, Rodriguez A, Wang M, Westin JR, Cheah C, Noorani M, Feng L, Davis RE, Neelapu SS. Strati P, et al. Among authors: feng l. Haematologica. 2020 Jul;105(7):1907-1913. doi: 10.3324/haematol.2019.230649. Epub 2019 Oct 10. Haematologica. 2020. PMID: 31601688 Free PMC article.
A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.
Strati P, Chihara D, Oki Y, Fayad LE, Fowler N, Nastoupil L, Romaguera JE, Samaniego F, Garg N, Feng L, Wesson ET, Ruben CE, Stafford MD, Nieto Y, Khouri IF, Hosing C, Horowitz SB, Kamble RT, Fanale MA. Strati P, et al. Among authors: feng l. Haematologica. 2018 Sep;103(9):e416-e418. doi: 10.3324/haematol.2018.187617. Epub 2018 Apr 5. Haematologica. 2018. PMID: 29622656 Free PMC article. Clinical Trial. No abstract available.
Frontline antibiotic therapy for early-stage Helicobacter pylori-negative gastric MALT lymphoma.
Strati P, Lee ST, Teegavarupu P, Karri A, Anireddy S, Hagemeister FB, Romaguera J, Fayad LE, Rodriguez MA, Samaniego F, Fowler N, Westin J, Wang M, Lee HJ, Pinnix C, Gunther JR, Dabaja B, Feng L, Davis RE, Neelapu SS. Strati P, et al. Among authors: feng l. Am J Hematol. 2019 Jun;94(6):E150-E153. doi: 10.1002/ajh.25447. Epub 2019 Mar 6. Am J Hematol. 2019. PMID: 30785215 Free article. No abstract available.
Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL.
Strati P, Ahmed MA, Nastoupil LJ, Feng L, Hagemeister FB, Fayad LE, Rodriguez MA, Samaniego F, Wang M, Westin JR, Lee HJ, Iyer SP, Parmar S, Ahmed S, Nair R, Steiner RE, Noorani M, Flowers CR, Davis RE, Fowler NH, Neelapu SS. Strati P, et al. Among authors: feng l. Leuk Lymphoma. 2020 Jun;61(6):1380-1387. doi: 10.1080/10428194.2020.1716221. Epub 2020 Jan 23. Leuk Lymphoma. 2020. PMID: 31971032
Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma.
Samaniego F, McLaughlin P, Neelapu SS, Feng L, Fanale M, Nastoupil L, Rodriguez MA, Pro B, Taylor E, Hagemeister FB, Fowler N. Samaniego F, et al. Among authors: feng l. Leuk Lymphoma. 2021 Jan;62(1):58-67. doi: 10.1080/10428194.2020.1821005. Epub 2020 Sep 14. Leuk Lymphoma. 2021. PMID: 32924687 Clinical Trial.
Long-term follow-up of lenalidomide and rituximab as initial treatment of follicular lymphoma.
Strati P, Jain P, Johnson RJ, Forbes S, Feng L, Samaniego F, Rodriguez MA, Fayad LE, Hagemeister F, Westin J, Wang M, Neelapu SS, Nastoupil LJ, Fowler NH. Strati P, et al. Among authors: feng l. Blood. 2021 Feb 25;137(8):1124-1129. doi: 10.1182/blood.2020007994. Blood. 2021. PMID: 32932518 Free PMC article. Clinical Trial. No abstract available.
A prospective study on early PET/CT scans during the first cycle of salvage chemotherapy for relapsed or refractory diffuse large B-cell lymphoma.
Cherng HJ, Chuang HH, Steiner R, Fayad L, Strati P, Nair R, Hagemeister F, Nastoupil LJ, Lee HJ, Neelapu SS, Flowers CR, Samaniego F, Rodriguez M, Macapinlac HA, Feng L, Westin J. Cherng HJ, et al. Among authors: feng l. Leuk Lymphoma. 2022 Jan;63(1):74-83. doi: 10.1080/10428194.2021.1971223. Epub 2021 Aug 26. Leuk Lymphoma. 2022. PMID: 34435552 Free PMC article. Clinical Trial.
Cardiovascular events in patients treated with chimeric antigen receptor T-cell therapy for aggressive B-cell lymphoma.
Steiner RE, Banchs J, Koutroumpakis E, Becnel M, Gutierrez C, Strati P, Pinnix CC, Feng L, Rondon G, Claussen C, Palaskas N, Karimzad K, Ahmed S, Neelapu SS, Shpall E, Wang M, Vega F, Westin J, Nastoupil LJ, Deswal A. Steiner RE, et al. Among authors: feng l. Haematologica. 2022 Jul 1;107(7):1555-1566. doi: 10.3324/haematol.2021.280009. Haematologica. 2022. PMID: 34758610 Free PMC article.
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma.
Nastoupil LJ, Chin CK, Westin JR, Fowler NH, Samaniego F, Cheng X, Ma MCJ, Wang Z, Chu F, Dsouza L, Obi C, Mims J, Feng L, Zhou S, Green M, Davis RE, Neelapu SS. Nastoupil LJ, et al. Among authors: feng l. Blood Adv. 2022 Feb 22;6(4):1143-1151. doi: 10.1182/bloodadvances.2021006240. Blood Adv. 2022. PMID: 35015819 Free PMC article. Clinical Trial.
11,802 results
You have reached the last available page of results. Please see the User Guide for more information.